Edition:
United Kingdom

Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

5,320JPY
20 Jul 2018
Change (% chg)

¥20 (+0.38%)
Prev Close
¥5,300
Open
¥5,310
Day's High
¥5,330
Day's Low
¥5,270
Volume
191,700
Avg. Vol
235,739
52-wk High
¥6,700
52-wk Low
¥4,560

Chart for

About

SAWAI PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company is engaged in the manufacture and sale of ethical drugs and proprietary drugs. The Company primarily provides central nerve system drugs, circulatory drugs, alimentary canal drugs, vitamin drugs, blood and body fluid drugs, metabolic medicinal... (more)

Overall

Beta: 0.46
Market Cap(Mil.): ¥247,727.09
Shares Outstanding(Mil.): 38.17
Dividend: 65.00
Yield (%): 2.00

Financials

  4555.T Industry Sector
P/E (TTM): 14.77 30.93 32.76
EPS (TTM): 439.49 -- --
ROI: 9.93 15.07 14.61
ROE: 12.12 16.60 16.34

BRIEF-R&I removes Sawai Pharmaceutical from rating monitor and affirms its rating at "A-"-R&I

* Rating and Investment Information, Inc. (R&I) removed the company from rating monitor-R&I

03 Apr 2018

REFILE-TABLE-Sawai Pharmaceutical- 9-MTH group results

(Adds company forecast. Accounting policy for forecast is IFRS) Feb 13 (Reuters)- Sawai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2017 Dec 31, 2016 Mar 31, 2018 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 116.54 101.38

13 Feb 2018

Earnings vs. Estimates